Elite in Otitis

Paola G. Marchisio

Milan, IT 
Elite in Otitis
Milan, IT 
OverviewLocationsClinical Research

Overview

Paola Marchisio practices in Milan, Italy. Ms. Marchisio and is rated as an Elite expert by MediFind in the treatment of Otitis. Her top areas of expertise are Otitis, Otitis Media with Effusion, Enlarged Adenoids, Myringotomy, and Adenoidectomy.

Her clinical research consists of co-authoring 248 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 70 articles in the study of Otitis.

Gender
Female

Locations

Milan, Italy
Other Locations
Florence, Italy
Perugia, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow-up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa
Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow-up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa
Enrollment Status: Completed
Publish Date: July 20, 2023
Intervention Type: Drug
Study Drug: Oleogel-S10
Study Phase: Phase 3
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
Enrollment Status: Completed
Publish Date: May 09, 2023
Intervention Type: Drug
Study Drugs: Fluticasone Furoate, Vilanterol
Study Phase: Phase 3
View 1 Less Clinical Trial

248 Total Publications

Corrigendum to "Omalizumab may protect allergic patients against COVID-19: A systematic review" [World Allergy Organ J 16 (2) (2023) 1-19].
Corrigendum to "Omalizumab may protect allergic patients against COVID-19: A systematic review" [World Allergy Organ J 16 (2) (2023) 1-19].
Journal: The World Allergy Organization journal
Published: June 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Marchisio's expertise for a condition
ConditionClose
View All 20 Advanced Conditions
View All 82 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile